Hospital study aims to find best way to monitor blood thinner dosing

NCT ID NCT06329921

ENROLLING_BY_INVITATION Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This study compares two methods for monitoring the blood thinner heparin in hospitalized patients with blood clots. One method uses a standard clotting test (PTT), while the other uses a newer test (anti-Xa). The goal is to see which method helps patients reach the right blood thinner level faster. About 700 adults at Vanderbilt University Hospital will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: unfractionated heparin
What this could lead to: If successful, this could show which monitoring method is better for quickly getting blood thinner levels right, potentially improving treatment for blood clots.
What could go wrong: This is a pragmatic trial comparing existing methods, not testing a new drug. Results may not apply to all hospitals or patients, and the study is observational in nature.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD CLOT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thrombotic disease venous thromboembolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CLOT THROMBOSIS

Contacts and locations

Locations

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.